Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation (2025)
- Authors:
- Lima, Thaís Santos de Almeida
- Zuelli, Fabiana Corsi
- Souza, Adriana J
- Colodete, Debora Akemi Endo
- Silva, Naielly Rodrigues da
- Verza, Flávia Alves
- Deakin, Bill
- Del Bel, Elaine Aparecida
- Louzada Júnior, Paulo
- Ben, Cristina Marta Del
- Guimarães, Francisco Silveira
- Nakaya, Helder Takashi Imoto
- Gomes, Felipe Villela
- USP affiliated authors: LOUZADA JÚNIOR, PAULO - FMRP ; BEN, CRISTINA MARTA DEL - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; NAKAYA, HELDER TAKASHI IMOTO - FCF ; GOMES, FELIPE VILLELA - FMRP ; LIMA, THAÍS SANTOS DE ALMEIDA - FMRP ; VERZA, FLÁVIA ALVES - FMRP
- Unidades: FMRP; FCF
- DOI: 10.1016/j.schres.2025.07.022
- Subjects: METOTREXATO; ESQUIZOFRENIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Schizophrenia Research
- ISSN: 0920-9964
- Volume/Número/Paginação/Ano: v. 284, p. 67–76, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LIMA, Thaís Santos de Almeida et al. Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation. Schizophrenia Research, v. 284, p. 67–76, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.schres.2025.07.022. Acesso em: 09 fev. 2026. -
APA
Lima, T. S. de A., Zuelli, F. C., Souza, A. J., Colodete, D. A. E., Silva, N. R. da, Verza, F. A., et al. (2025). Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation. Schizophrenia Research, 284, 67–76. doi:10.1016/j.schres.2025.07.022 -
NLM
Lima TS de A, Zuelli FC, Souza AJ, Colodete DAE, Silva NR da, Verza FA, Deakin B, Del Bel EA, Louzada Júnior P, Ben CMD, Guimarães FS, Nakaya HTI, Gomes FV. Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation [Internet]. Schizophrenia Research. 2025 ; 284 67–76.[citado 2026 fev. 09 ] Available from: https://dx.doi.org/10.1016/j.schres.2025.07.022 -
Vancouver
Lima TS de A, Zuelli FC, Souza AJ, Colodete DAE, Silva NR da, Verza FA, Deakin B, Del Bel EA, Louzada Júnior P, Ben CMD, Guimarães FS, Nakaya HTI, Gomes FV. Low-dose methotrexate as a potential treatment for schizophrenia via astrocytic and neuroimmune modulation [Internet]. Schizophrenia Research. 2025 ; 284 67–76.[citado 2026 fev. 09 ] Available from: https://dx.doi.org/10.1016/j.schres.2025.07.022 - Medicamentos antipsicóticos
- Antinuclear antibodies testing as a routine screening for systemic lupus erythematosus in patients presenting first-episode psychosis
- Quantification of the serum levels of NR1 and NR2 NMDA receptor in patients in the first episode psychosis
- Neutrophil Extracellular Traps (NETs): a functional cellular mechanism in schizophrenia and implications of early-life stress
- Degradation of perineuronal nets in the ventral hippocampus of adult rats recreates an adolescent-like phenotype of stress susceptibility
- Levetiracetam attenuates adolescent stress-induced behavioral and electrophysiological changes associated with schizophrenia in adult rats
- Differential impact of adolescent or adult stress on behavior and cortical Parvalbumin interneurons and perineuronal nets in male and female mice
- Neutrophin brain derived neurotrophic factor (BDBF)in psychiatric systemic lupus erythematosus
- Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus
- Tract-based statistics in first episode psychosis: preliminary results depending on substance abuse comorbidity
Informações sobre o DOI: 10.1016/j.schres.2025.07.022 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3272097.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
